Treatment, Medication & Supplement Directory
A comprehensive encyclopedia of medicines, chemotherapy protocols, targeted and immune therapies, supplements, Chinese herbal formulas, Traditional Chinese Veterinary Medicine (TCVM) approaches, and supportive-care options used or discussed in canine and feline tumor care. Directory entries explain what each option is, where it may fit, its evidence and safety boundaries, and what to discuss with a veterinarian; they are references, not individualized prescriptions or rankings.
Taxane Chemotherapy: Formulation, Infusion, and Evidence Questions
Taxanes disrupt microtubule dynamics, but formulation, infusion reactions, species experience, and veterinary evidence differ enough that product names are not interchangeable.
Read moreL-Asparaginase in Lymphoid Cancer Protocols
L-asparaginase is an enzyme-based antineoplastic used in selected lymphoma or leukemia protocols, with hypersensitivity and protocol-timing considerations.
Read moreNamed profile Tanovea (Rabacfosadine): FDA-Approved Injectable Canine Lymphoma TherapyRepresentative category illustration – no product packaging is shown.Tanovea (Rabacfosadine): FDA-Approved Injectable Canine Lymphoma Therapy
Rabacfosadine is a canine lymphoma drug whose current official label, patient selection, cumulative risks, and availability must be verified before use.
Read moreCisplatin in Dogs: Species-Specific and Kidney-Safety Boundary
Cisplatin is a platinum chemotherapy used only in carefully selected veterinary settings; it has major kidney, gastrointestinal, infusion, and species-specific hazards.
Read more
Named profile Stelfonta (Tigilanol Tiglate): Intratumoral Canine Mast Cell Tumor TherapyRepresentative category illustration – no product packaging is shown.Stelfonta (Tigilanol Tiglate): Intratumoral Canine Mast Cell Tumor Therapy
Stelfonta is an FDA-approved intratumoral treatment for narrowly defined canine mast cell tumors, with important current warnings about degranulation, wounds, pain, tissue loss, amputation, and death.
Read more
Maropitant for Nausea and Vomiting Support in Cancer Care
Maropitant is a prescription antiemetic used for selected dogs and cats, but controlling vomiting does not identify or resolve every cause of nausea or gastrointestinal disease.
Read moreOndansetron for Persistent Nausea: Role and Interaction Review
Ondansetron is a serotonin-receptor antiemetic used by veterinarians for selected nausea and vomiting, often when one pathway or medicine is not enough.
Read moreMetoclopramide: Antiemetic and Motility Questions in Oncology
Metoclopramide has antiemetic and upper-gastrointestinal motility effects, making obstruction, neurologic history, cause, route, and interactions central to safe selection.
Read more
Opioids in Veterinary Cancer Pain and Crisis Care
Opioids are controlled prescription analgesics used in selected acute, severe, perioperative, and palliative pain plans under route-, product-, and jurisdiction-specific oversight.
Read moreBisphosphonates for Tumor-Associated Bone Pain
Intravenous bisphosphonates may be considered for selected tumor-associated bone pain or skeletal complications, with kidney, mineral, dental, and infusion review.
Read more
Named profile Gilvetmab: Canine PD-1 Immunotherapy and Conditional-Licence ProfileRepresentative category illustration – no product packaging is shown.Gilvetmab: Canine PD-1 Immunotherapy and Conditional-Licence Profile
gilvetmab is covered as caninized anti-pd-1 monoclonal antibody immune-checkpoint inhibitor, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.
Read moreNamed profile Oncept IL-2: Feline Fibrosarcoma Immunotherapy and EU Label ProfileRepresentative category illustration – no product packaging is shown.Oncept IL-2: Feline Fibrosarcoma Immunotherapy and EU Label Profile
feline interleukin-2 recombinant canarypox virus (vCP1338) is covered as veterinary biologic immunotherapy used with surgery and radiotherapy, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a…
Read more